Cell surface glycoengineering improves selectin-mediated adhesion of mesenchymal stem cells (MSCs) and cardiosphere-derived cells (CDCs): Pilot validation in porcine ischemia-reperfusion model

• Published in: Biomaterials Vol. 74; pp. 19 - 30
• Main Authors: Lo, Chi Y, Weil, Brian R, Palka, Beth A, Momeni, Arezoo, Canty, John M, Neelamegham, Sriram
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.01.2016
• Subjects: Adhesion molecule; Advanced Basic Science; Animals; Blood flow; Cell adhesion; Cell Adhesion - physiology; Cell Membrane - metabolism; Cells, Cultured; Cellular; Dentistry; Disease Models, Animal; Fucosyltransferases - metabolism; Glycoproteins - metabolism; Homing; Injury prevention; Joining; Mesenchymal stem cells; Mesenchymal Stromal Cells - cytology; Myocytes, Cardiac - cytology; Pilot Projects; Pilots; PSGL-1; Recombinant; Recombinant protein; Reperfusion Injury - therapy; Selectin; Selectins - physiology; Shear; Sialyl Lewis-X; Stem cells; Swine; Selectin; Cell adhesion; Adhesion molecule; PSGL-1; Sialyl Lewis-X; Recombinant protein; Mesenchymal stem cells; Blood flow
• ISSN: 0142-9612; 1878-5905
• DOI: 10.1016/j.biomaterials.2015.09.026

Abstract Promising results are emerging in clinical trials focused on stem cell therapy for cardiology applications. However, the low homing and engraftment of the injected cells to target tissue continues to be a problem. Cellular glycoengineering can address this limitation by enabling the targeting of stem cells to sites of vascular injury/inflammation. Two such glycoengineering methods are presented here: i. The non-covalent incorporation of a P-selectin glycoprotein ligand-1 (PSGL-1) mimetic 19Fc[FUT7+ ] via lipid-protein G fusion intermediates that intercalate onto the cell surface, and ii. Over-expression of the α(1,3)fucosyltransferse FUT7 in cells. Results demonstrate the efficient coupling of 19Fc[FUT7+ ] onto both cardiosphere-derived cells (CDCs) and mesenchymal stem cells (MSCs), with coupling being more efficient when using protein G fused to single-tailed palmitic acid rather than double-tailed DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine). This non-covalent cellular modification was mild since cell proliferation and stem-cell marker expression was unaltered. Whereas coupling using 19Fc[FUT7+ ] enhanced cell capture on recombinant P-selectin or CHO-P cell surfaces, α(1,3)fucosylation was necessary for robust binding to E-selectin and inflamed endothelial cells under shear. Pilot studies confirm the safety and homing efficacy of the modified stem cells to sites of ischemia-reperfusion in the porcine heart. Overall, glycoengineering with physiological selectin-ligands may enhance stem cell engraftment.